REQUEST A DEMO
Total
USD $0.00
Search more companies

Lilly Hungaria Kft (Hungary)

Main Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Scientific Research and Development Services
Full name: Lilly Hungaria Kft Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

Lilly Hungaria Kft is based in Hungary, with the head office in Budapest. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on November 04, 1991. The total number of employees is currently 41 (2026). The latest financial highlights indicate a net sales revenue increase of 90.41% in 2025. Its’ total assets recorded a growth of 57.1%. In 2025, Lilly Hungaria Kft’s net profit margin decreased by 0.32%.

Headquarters
Madach I ut 13-14. VII. em.
Budapest; Budapest; Postal Code: 1075

Contact Details: Purchase the Lilly Hungaria Kft report to view the information.

Website: http://www.lilly.hu

Basic Information
Total Employees:
Purchase the Lilly Hungaria Kft report to view the information.
Registered Capital:
Purchase the Lilly Hungaria Kft report to view the information.
Financial Auditors:
Purchase the Lilly Hungaria Kft report to view the information.
Incorporation Date:
November 04, 1991
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Lilly Hungaria Kft report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
90.41%
Total Operating Revenue
86.54%
Operating Profit
74.67%
EBITDA
73.42%
Net Profit/Loss for the Period
82.65%
Total Assets
57.1%
Total Equity
63.21%
Operating Profit Margin
-0.74%
Net Profit Margin
-0.32%
Return on Equity (ROE)
4.15%
Quick Ratio
0.1%
Cash Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?